Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA (CATARA)
This study has been withdrawn prior to enrollment.
(decision of sponsor to withdraw before initiation; 0 patients enrolled)
First Posted: September 17, 2010
Last Update Posted: February 5, 2016
Information provided by (Responsible Party):
Mark Genovese, Stanford University